Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Cystic Fibrosis Registry of Ireland
Homepage:
cfri.ie
Alternate name:
Cystic Fibrosis Registry Ireland
ROR:
017gdmk57
OpenAlex ID:
I4405283205
Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis
2017
·
Emma Reece
, Ricardo Segurado
, et al.
·
BMC Pulmonary Medicine
·
119
PDF
Epidemiology of CF: How registries can be used to advance our understanding of the CF population
2017
·
Abaigeal D. Jackson
, Christopher H. Goss
·
Journal of Cystic Fibrosis
·
97
PDF
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial
2023
·
Paul McNally
, Karen Lester
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
94
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
2021
·
Lutz Naehrlich
, Annalisa Orenti
, et al.
·
Journal of Cystic Fibrosis
·
62
PDF
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study
2021
·
Edward F. McKone
, Cono Ariti
, et al.
·
European Respiratory Journal
·
60
PDF
Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of Ireland
2018
·
Laura Kirwan
, Godfrey Fletcher
, et al.
·
Annals of the American Thoracic Society
·
60
Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis
2011
·
A. D. Jackson
, L. Daly
, et al.
·
Thorax
·
38
PDF
The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited
2010
·
Abaigeal D. Jackson
, Leslie Daly
, et al.
·
Journal of Cystic Fibrosis
·
25
PDF
OUP accepted manuscript
2019
·
Abaigeal D Jackson
, Laura Kirwan
, et al.
·
European Journal of Public Health
·
24
PDF
Telehealth in Cystic Fibrosis. A systematic review incorporating a novel scoring system and expert weighting to identify a ‘top 10 manuscripts’ to inform future best practices implementation
2023
·
Tamara Vagg
, Shivanthan Shanthikumar
, et al.
·
Journal of Cystic Fibrosis
·
21
PDF
The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting
2023
·
Paul McNally
, Barry Linnane
, et al.
·
Respiratory Research
·
15
PDF
Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008–2012
2017
·
Abaigeal D. Jackson
, Andrew L. Jackson
, et al.
·
PharmacoEconomics
·
14
Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
2024
·
Julie Semenchuk
, Yumi Naito
, et al.
·
Journal of Cystic Fibrosis
·
9
PDF
Periodontal disease prevalence and oral hygiene status of adults with cystic fibrosis: A case–control study
2024
·
Niamh Coffey
, Fiona O'Leary
, et al.
·
Journal Of Clinical Periodontology
·
5
PDF
ECFSPR 2024 Annual Data Report
2026
·
Zolin, Anna
, Adamoli, Arianna
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
·
4
Impact of 2 years of treatment with elexacaftor/tezacaftor/ivacaftor on longitudinal changes in structural lung disease in people with cystic fibrosis: results from the RECOVER trial
2026
·
Paul McNally
, Karen Lester
, et al.
·
Annals of the American Thoracic Society
·
4
Caries in a cohort of adults with cystic fibrosis: a cross-sectional study
2025
·
Fiona O´Leary
, Niamh Coffey
, et al.
·
BDJ
·
4
PDF
Real-world improvement in ultra-low-dose thoracic computed tomography scores, systemic inflammatory markers and patient-reported outcome measures after elexacaftor/tezacaftor/ivacaftor treatment
2024
·
Hisham Ibrahim
, Alexander T. O'Mahony
, et al.
·
ERJ Open Research
·
4
Dornase alfa and rate of lung function decline in European patients with cystic fibrosis: A retrospective registry cohort study
2020
·
Edward F. McKone
, Abaigeal D. Jackson
, et al.
·
Journal of Cystic Fibrosis
·
4
The prevalence of developmental defects of enamel in a cohort of adults with cystic fibrosis – A cross sectional study
2024
·
FionaO'Leary
, Niamh Coffey
, et al.
·
Journal of Dentistry
·
3
P057 Measuring adherence to chronic therapies over the first year of treatment with elexacaftor/tezacaftor/ivacaftor (ETI) in people with cystic fibrosis (CF) aged 6–11 years – the RECOVER study
2024
·
S. Sutton
, J. Hayden
, et al.
·
Journal of Cystic Fibrosis
·
2
Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry
2026
·
Annalisa Orenti
, Kris De Boeck
, et al.
·
The Lancet Respiratory Medicine
·
1
Outcomes of SARS-CoV-2 infection post-solid organ transplantation in the cystic fibrosis population
2026
·
Julie Semenchuk
, Yumi Naito
, et al.
·
Journal of Cystic Fibrosis
·
1
PDF
EPS4.01 Impact of 18 months of treatment with elexacaftor/tezacaftor/ivacaftor on clinical outcomes in children aged 6–11 with CF – the RECOVER study
2024
·
P. McNally
, K. Lester
, et al.
·
Journal of Cystic Fibrosis
·
1
WS15.05 Improvements in structural lung disease in people with CF aged 12 and above on elexacaftor/tezacaftor/ivacaftor are sustained for up to two years
2024
·
P. McNally
, K. Lester
, et al.
·
Journal of Cystic Fibrosis
·
1
Show more works
View as search
Works count:
64
Citation count:
1,588
Year
Topic
Type